Invest now
Bajaj Healthcare share price
High risk
You have to be logged in to add this to Watchlist.- ₹321.60(-3.74%)September 15, 2026 15:29:49 PM IST
- NSE
- BSE
- Vol : 114.20 K (NSE + BSE)Last 20 day avg : 127.69 K
Bajaj Healthcare is trading -3.74% lower at Rs 321.60 as compared to its last closing price. Bajaj Healthcare has been trading in the price range of 334.20 & 319.70. Bajaj Healthcare has given -19.53% in this year & 3.92% in the last 5 days. Bajaj Healthcare has TTM P/E ratio 48.84 as compared to the sector P/E of 36.32.The company posted a net profit of 13.70 Crores in its last quarter.Listed peers of Bajaj Healthcare include Sun Pharmaceutical Industries (-0.38%), Divi's Laboratories (-1.46%), Torrent Pharmaceuticals (-2.51%).The Mutual Fund holding in Bajaj Healthcare was at 1.69% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Bajaj Healthcare was at 2.19% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 16 Sep 2026, 03:18 AM IST
- BetaHigh volatility1.19Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.47The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.45Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-1.90The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Bajaj Healthcare News
Bajaj Healthcare Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,835.00 | -0.38 | 4,40,267.60 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,190.00 | -1.46 | 2,43,965.63 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,850.00 | -2.51 | 1,88,871.70 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,361.00 | -0.29 | 1,09,949.54 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,099.00 | -1.83 | 1,09,625.67 | 21.19 | 4.24 | 0.09 | 14.22 |
Mutual Fund Ownership
View allBajaj Healthcare Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-20 | Quarterly Results |
| 2026-05-08 | Audited Results & Final Dividend |
| 2026-03-18 | To consider Fund Raising |
| 2026-01-16 | Quarterly Results |
| 2025-10-17 | Quarterly Results |
About the company Bajaj Healthcare
- IndustryBiotechnology & Drugs
- ISININE411U01027
- BSE Code539872
- NSE CodeBAJAJHCARE
Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in activities of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), bulk drugs, branded and generic formulations. It is focused on development, manufacturing and supply of amino acids, nutritional supplements and API for pharmaceutical, nutraceuticals and food industries. It operates through three segments: APIs, Finished Dosage Formulations (FDFs), and Intermediates. Its APIs include Ascorbic Acid IP, Sodium Ascorbate, Ferrous Ascorbate, and others. Its Intermediary products include Calcium Phosphoryl Choline Chloride (CPCC) and Chlorhexidine (CH Base). It offers a range of FDFs forms, including tablets, caplets, capsules, and oral powders, all available in bulk quantities. The FDFs products include Cholecalciferol Sachet, Ticagrelor Tablet, Pancreatin Capsules, levofloxacin Tablets IP, Bisacodyl Tablet IP, and others.
Bajaj Healthcare Share Price FAQs
Bajaj Healthcare is trading at 321.60 as on Tue Sep 15 2026 09:59:49. This is -3.74% lower as compared to its previous closing price of 334.10.
The market capitalization of Bajaj Healthcare is 1082.67 Cr as on Tue Sep 15 2026 09:59:49.
The 52 wk high for Bajaj Healthcare is 516.20 whereas the 52 wk low is 272.45
Bajaj Healthcare can be analyzed on the following key metrics -
- TTM P/E: 48.84
- Sector P/E: 36.32
- Dividend Yield: 0.45%
- D/E ratio: -
Bajaj Healthcare reported a net profit of 15.77 Cr in 2026.
The Mutual Fund Shareholding was 1.69% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Bajaj Healthcare QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.